Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Remke

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Nature Communications|June 1, 2022
Persister state-directed transitioning and vulnerability in melanomaHeike Chauvistré, Batool Shannan, Sheena M Daignault-Mill, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
The Journal of Clinical Investigation|October 26, 2018
DNA hypermethylation within TERT promoter upregulates TERT expression in cancerDonghyun D Lee, Ricardo Leão, Martin Komosa, et al.
Nature Genetics|December 10, 2013
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMRClaudia L Kleinman, Noha Gerges, Simon Papillon-Cavanagh, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Brain : a Journal of Neurology|March 1, 2018
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibitionVeronica Ferrucci, Pasqualino de Antonellis, Francesco Paolo Pennino, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
The Lancet. Oncology|October 22, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Nature Communications|June 1, 2022
Persister state-directed transitioning and vulnerability in melanomaHeike Chauvistré, Batool Shannan, Sheena M Daignault-Mill, et al.
Cancer Cell|August 16, 2011
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymomaHendrik Witt, Stephen C Mack, Marina Ryzhova, et al.
The Journal of Clinical Investigation|October 26, 2018
DNA hypermethylation within TERT promoter upregulates TERT expression in cancerDonghyun D Lee, Ricardo Leão, Martin Komosa, et al.
Nature Genetics|December 10, 2013
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMRClaudia L Kleinman, Noha Gerges, Simon Papillon-Cavanagh, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Brain : a Journal of Neurology|March 1, 2018
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibitionVeronica Ferrucci, Pasqualino de Antonellis, Francesco Paolo Pennino, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
The Lancet. Oncology|October 22, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Pageof 19